Microclots occur in the blood of Long Covid sufferers. Once these microclots are removed, by Help Apheresis etc., the symptoms reduce/resolve.
This is really of great help and value to everyone suffering from Long Covid, it is a well thought through diagnostic test that gives a very good indication if you have microclots, the level of severity they occur in your blood and if further investigation for treatment is meaningful.
Dr. Gustavo Aguirre-Chang and Dr. Aurora Trujillo F. developed this diagnostic test in August 2022.
Now you can take the free online version of the microclots indication test and get you your results by email.
Find the test here or klick the button below: https://apheresiscenter.eu/microclots-test
Find the free offline version of Dr. Gustavo Aguirre-Chang and Dr. Aurora Trujillo F.here: Link
A new Long Covid and microclot blood test used by clinicians based on the latest research by measuring the Angiotensin-1 and P-Selective (Angiogenesis markers): https://molmed.biomedcentral.com/articles/10.1186/s10020-022-00548-8
'Fourteen vasculature transformation blood biomarkers were significantly elevated in Long-COVID outpatients, versus acutely ill COVID-19 inpatients and healthy controls subjects (P < 0.05). A unique two biomarker profile consisting of ANG-1/P-SEL was developed with machine learning, providing a classification accuracy for Long-COVID status of 96%. Individually, ANG-1 and P-SEL had excellent sensitivity and specificity for Long-COVID status (AUC = 1.00, P < 0.0001; validated in a secondary cohort). Specific to Long-COVID, ANG-1 levels were associated with female sex and a lack of disease interventions at follow-up (P < 0.05).'
Currently a blood test for microclots is not avaialable at clinics/publicly. Only research laboratories undertake confocal fluoresent microscopy tests. Research has shown, that ALL people with Long Covid have microclots and 80% of people with MECFS. A prediction for treatment outcome is not possible yet by fluorescent confocal microscopy.
This method is researched currently, it is unsure if and when it will be publicly available.